Stephen O’Hara is a scientist with over 50 publications, 60+ patents and chapters in a number of books.
Having worked in the healthcare and biotechnological industries for more than 30 years, he has a wealth of experience through previous directorship roles with major public and private companies, including the NHS and US corporation 3M. Highly adept at identifying early opportunities and creating products which satisfy an unmet global need, he founded life sciences company OptiBiotix in 2012 to develop compounds which modulate the human microbiome and deliver revolutionary health solutions.
Stephen has been instrumental in making OptiBiotix a world leader in microbiome science, promoting its potential and developing solutions to meet large wellbeing and nutrition market needs. He has also acted as Non-Executive Director of life sciences company SkinBioTherapeutics PLC since April 2017, developing probiotic bacteria solutions for the skin care industry.